“…A previous Brazilian study showed that patients with pemphigus had an increased risk of metabolic syndrome because of steroid treatment of pemphigus. 36 In our study, the incidence of PV and PF was increased in individuals with hypertension, dyslipidemia and diabetes mellitus. Considering that the side-effects of glucocorticoids include osteoporosis, atherosclerosis, increased blood pressure, insulin resistance, glucose intolerance, hyperlipidemia and central obesity, the importance of comorbid metabolic diseases in PF and PV individuals should be emphasized.…”